New Biomarker Identified for Early Diagnosis of Pancreatic Cancer
CSIC scientists link the presence of AXL protein to early diagnosis of pancreatic tumors
02-Feb-2022 -
A team co-led by CSIC researchers has identified a new biomarker for early diagnosis of the most common pancreatic cancer, pancreatic ductal adenocarcinoma, which is the third leading cause of cancer death in developed countries (in Spain there were about 8,700 cases in 2021). This work, ...
biomarkers
pancreatic cancer